Beta-adrenoblockers use in combination of cardiovascular and pulmonary diseases

Beta-adrenoblockers use in combination of cardiovascular and pulmonary diseases

Bibliographic Details
Main Authors:	V I Makolkin, S I Ovcharenko, I V Litvinova
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2008-08-01
Series:	Терапевтический архив
Subjects:	review β-adrenoblockers coronary heart disease chronic obstructive pulmonary disease nebivolo
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/30250

Similar Items

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
by: V. I. Makolkin, et al.
Published: (1970-01-01)

Current position of beta-adrenoblockers in coronary heart disease management: information for clinicians
by: I. A. Libov, et al.
Published: (2009-04-01)

Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features
by: O. D. Ostroumova, et al.
Published: (2011-06-01)

Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
by: A. E. Radzevich, et al.
Published: (1970-01-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

CARDIO-SELECTIVE BETA-ADRENOBLOCKER SAFETY IN CARDIOVASCULAR DISEASE TREATMENT AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: B. V. Trapeznikova, et al.
Published: (2010-06-01)

Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01)

Beta-adrenoblockers in clinical practice: is there any difference?
by: D. V. Nebieridze, et al.
Published: (2007-06-01)

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)

Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure
by: E. V. Privalova
Published: (2007-06-01)

REASONS FOR Β-ADRENOBLOCKER USE IN ARTERIAL HYPERTENSION: ONE MORE TIME ABOUT PRO AND CONTRA
by: V. I. Makolkin
Published: (2016-01-01)

Differential approach in selecting beta-adrenoblocker therapy for patients with chronic heart failure and anaemia
by: T. M. Uskach, et al.
Published: (2012-04-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01)

CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA
by: S. Yu. Martsevich, et al.
Published: (2017-09-01)

Target organs in patients with post-infarction chronic heart failure: dynamics during complex therapy including beta-adrenoblockers
by: I. P. Rubesh, et al.
Published: (2008-08-01)

Beta-adrenoblockers in cardiology practice
by: A. A. Garganeeva
Published: (2010-10-01)

Rational pharmacotherapy of chronic obstructive pulmonary disease in elderly patients with cardiac arrhythmias: the role of a betaadrenoblocker bisoprolol
by: D. A. Kadaeva, et al.
Published: (2010-10-01)

Differential beta-adrenoblocker therapy in chronic heart failure: the role of age, gender, and co-morbidity
by: S. N. Tereshchenko, et al.
Published: (2009-10-01)

Cardiovascular and chronic obstructive pulmonary diseases: pathophysiological processes and treatment tactics
by: L. G. Ambatiello, et al.
Published: (2020-03-01)

URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
by: M. P. Savenkov, et al.
Published: (2016-01-01)

Myocardial infarction in elderly patients.Role of beta-adrenoblockers in its treatment and secondaryprevention
by: I A Komissarenko
Published: (2003-11-01)

Use of nebivolol in patients with idiopathic pulmonary hypertension: Results of the pilot study
by: T V Martyniuk, et al.
Published: (2012-12-01)

Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)

Superselective beta-adrenoblocker Nebivolol in patients with cardiovascular pathology and obstructive pulmonary syndrome
by: S. I. Ovcharenko, et al.
Published: (2006-04-01)

Cardioselective beta-adrenoblocker bisoprolol in treating hypertensive patients with heart failure
by: A. N. Britov
Published: (2005-06-01)

Could secondary prevention of coronary heart disease be more effective?
by: V. I. Makolkin
Published: (2010-02-01)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
by: I. T. Murkamilov, et al.
Published: (2017-07-01)

Clinical characteristics of the respiratory and cardiovascular systems in patients with combination of chronic obstructive pulmonary disease and heart failure
by: I. I. Vyshnyvetskyy, et al.
Published: (2017-06-01)

Aortic stiffness in chronic obstructive pulmonary disease concurrent with coronary heart disease
by: Vera Afanas'evna Nevzorova, et al.
Published: (2010-03-01)

Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

The combined drug ascoril in the treatment of patients with chronic obstructive pulmonary disease concurrent with coronary heart disease
by: N Iu Grigor'eva, et al.
Published: (2013-08-01)

Perioperative beta-adrenoblocker therapy and cardiovascular event risk: are all the problems solved?
by: Yu. M. Lopatin
Published: (2009-12-01)

Coronary artery status in patients with coronary heart disease and chronic obstructive pulmonary disease: results of selective coronary angiography
by: N. Yu. Grigorieva, et al.
Published: (2012-10-01)

FORECASTING CORONARY EVENTS BASED ON THE ANALYSIS OF THE DYNAMICS OF MORPHOFUNCTIONAL PARAMETERS OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE NORTH
by: D. A. Dolgopolova, et al.
Published: (2018-02-01)

Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapy
by: D. V. Duplyakov
Published: (2009-08-01)

Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
by: V. B. Mychka
Published: (2012-06-01)

Modern management of arterial hypertension: has the position of beta-adrenoblockers changed
by: S. Yu. Martsevich
Published: (2007-08-01)